61844-85-7 , Heparin derived dp4 saccharide ammonium salt ,
Tetrasaccharide (dp4)
C24H40N2O39S6 / 1172.95
MFCD15145459
Heparin is a linear sulphated polysaccharide comprising contiguous disaccharide units of a uronic acid and a derivative of 2-amino-2-deoxy-D-glucose. The heparin tetrasaccharide can be obtained from the degradation of heparin with the lyase enzymes isolated from Flavobacterium heparinum, which yields oligosaccharides terminated at the non-reducing end by the unsaturated unit, 4-deoxy-α-L-threo-hex-4-enopyranosyl uronic acid or its 2-0-sulphated derivative. The major product following lyase degradation is the trisulphated derivative DUA-2S + GlcNS-6S (unsaturated disaccharide). Other oligosaccharides such as the tetrasaccharide, illustrated below, can be produced by the lytic degradation of heparin (Moffat, 1991).
Heparin-derived tetrasaccharide (HDT) is a naturally occurring disaccharide unit made up of glucosamine and glucuronic acid residues. It is derived from heparin, a high molecular weight glycosaminoglycan that is primarily used as an anticoagulation agent in the management of thromboembolic disorders. Researchers have been keen to isolate bioactive fragments from heparin to develop new drugs and vaccines that target specific biological processes.
Physical and Chemical Properties
HDT is a tetrasaccharide consisting of four sugar residues linked through glycosidic bonds. It has a molecular weight of 1200 Da and is highly polar and water-soluble. HDT is stable in acidic and neutral conditions, but it is easily degraded by heparinase enzymes or prolonged exposure to high pH environments. The degree of sulfation and acetylation of HDT varies, which affects its biological activity and interaction with other molecules.
Synthesis and Characterization
HDT can be synthesized by partial depolymerization of heparin or through chemical synthesis. The latter method involves the coupling of individual sugar residues in a specific order using various protecting groups and condensation reagents. Characterization of HDT involves various techniques such as nuclear magnetic resonance, mass spectrometry, and high-performance liquid chromatography.
Analytical Methods
Analytical methods that are commonly used to analyze HDT include gel electrophoresis, capillary electrophoresis, and enzymatic assays. These techniques are used to determine the purity, degree of sulfation, molecular weight, and biological activity of HDT.
Biological Properties
HDT exhibits various biological activities, including anti-inflammatory, anticoagulation, antithrombotic, and anti-angiogenic effects. It interacts with various proteins, including chemokines, growth factors, and enzymes, and modulates their biological functions. HDT has been shown to inhibit the activity of factor Xa, a key enzyme in the coagulation cascade, by binding to its active site.
Toxicity and Safety in Scientific Experiments
Studies on the toxicity and safety of HDT in scientific experiments have shown that it has a low cytotoxicity and does not induce significant adverse effects. However, further studies need to be conducted to assess the potential long-term effects of HDT exposure on various cell types and organisms.
Applications in Scientific Experiments
Due to its various biological activities, HDT has shown great potential as a therapeutic agent or vaccine component. It can be used in drug discovery programs to develop new anti-inflammatory, anti-thrombotic, or anti-cancer compounds. HDT conjugated with carriers such as proteins or liposomes can also be used to design new vaccines. Additionally, HDT can be used as a scaffold to create new glycan-based materials.
Current State of Research
Studies on HDT are ongoing, with many researchers focusing on developing cost-effective and efficient methods for HDT synthesis and characterization. Researchers are also exploring new applications of HDT in various fields, including regenerative medicine and tissue engineering.
Potential Implications in Various Fields of Research and Industry
HDT has the potential to revolutionize various fields of research and industry. For example, HDT can be used to develop new drugs to manage thromboembolic disorders, chronic inflammation, or cancer. HDT can also be used to design new vaccines to combat infectious diseases. In the field of regenerative medicine, HDT can be used to stimulate tissue repair and regeneration. Additionally, HDT-based biomaterials can be used in tissue engineering applications.
Limitations and Future Directions
Despite the potential applications of HDT in various fields, some limitations still exist. For example, the cost of HDT synthesis is still high, making it unaffordable for many researchers. Further studies need to be conducted to assess the long-term safety effects of HDT exposure and its interaction with other drugs. Finally, researchers need to investigate the biological activity of HDT more thoroughly to identify new therapeutic targets.
Future Directions:
- Investigate HDT's interaction with other molecules in more depth
- Evaluate HDT's potential in wound healing and tissue repair
- Assess HDT as a possible treatment for autoimmune diseases
- Investigate HDT's potential in the development of new vaccine adjuvants
- Investigate HDT's role as a biomarker for various diseases
- Conduct more studies to explore HDT's potential in the treatment of cancer
- Investigate the possibility of using HDT for the modification of biomaterial surfaces
- Develop new methods for HDT synthesis that are cost-effective and efficient.
- Investigate potential combinatory therapeutic treatments including HDT.
- Determine whether combining HDT with other compounds could enhance its effectiveness in treating thromboembolic disorders, chronic inflammation, or cancer.
- Investigate the potential role of HDT in immunomodulation.
- Study the effects of HDT on the immune system and cytokine signaling.
CAS Number | 61844-85-7 |
Product Name | Heparin-derived tetrasaccharide |
IUPAC Name | (2R,3R,4S)-2-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-2-carboxy-6-[(2R,3S,4R,5R,6S)-4,6-dihydroxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-4-hydroxy-3-sulfooxy-3,4-dihydro-2H-pyran-6-carboxylic acid |
Molecular Formula | C24H38N2O35S5 |
Molecular Weight | 1074.9 g/mol |
InChI | InChI=1S/C24H38N2O35S5/c27-4-1-5(19(32)33)55-24(14(4)61-66(49,50)51)58-16-7(3-53-65(46,47)48)56-22(9(11(16)29)26-63(40,41)42)59-17-12(30)13(31)23(60-18(17)20(34)35)57-15-6(2-52-64(43,44)45)54-21(36)8(10(15)28)25-62(37,38)39/h1,4,6-18,21-31,36H,2-3H2,(H,32,33)(H,34,35)(H,37,38,39)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)/t4-,6+,7+,8+,9+,10+,11+,12+,13+,14+,15+,16+,17-,18+,21-,22+,23+,24-/m0/s1 |
InChI Key | QTSOBXZFMHJWGX-UQSIALEXSA-N |
SMILES | C1=C(OC(C(C1O)OS(=O)(=O)O)OC2C(OC(C(C2O)NS(=O)(=O)O)OC3C(C(C(OC3C(=O)O)OC4C(OC(C(C4O)NS(=O)(=O)O)O)COS(=O)(=O)O)O)O)COS(=O)(=O)O)C(=O)O |
Canonical SMILES | C1=C(OC(C(C1O)OS(=O)(=O)O)OC2C(OC(C(C2O)NS(=O)(=O)O)OC3C(C(C(OC3C(=O)O)OC4C(OC(C(C4O)NS(=O)(=O)O)O)COS(=O)(=O)O)O)O)COS(=O)(=O)O)C(=O)O |
Isomeric SMILES | C1=C(O[C@H]([C@@H]([C@H]1O)OS(=O)(=O)O)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)NS(=O)(=O)O)O[C@H]3[C@@H]([C@H]([C@@H](O[C@H]3C(=O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)NS(=O)(=O)O)O)COS(=O)(=O)O)O)O)COS(=O)(=O)O)C(=O)O |
联系人:邢经理
手机: 18310328607 , 13621067991,13552979007
电话:86+10-61274189
邮箱:chemsynlab@163.com, zhangchao@chemsynlab.com
地址: 北京市大兴区金苑路26号1幢4层411室